790

We are creating a clinical trial recruitment piece directed to patients evaluating the use of a marketed product for a new use. The study will evaluate the use of our product in combination with another marketed product and the inclusion criteria include the use of prior agents. To improve patient comprehension of the study and the inclusion criteria, we would like to include the marketed names of the combination product and the prior agents. However, the "Clinical Trial Recruitment" section of the Health Canada policy document "The Distinction Between Advertising and Other Activities" states 'no reference is made to the drug manufacturer's name, or to the name of the drug under investigation.' To clarify, does that mean we cannot include the marketed product name or the ingredient name of any agents in the piece?

Yes.

790

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée.

quatre × deux =

Retour en haut